Get started
Author

Ru Feng

Treatment of Patients with Relapsed or Refractory Mantle–Cell Lymphoma with Zanubrutinib, a Selective Inhibitor of Bruton's Tyrosine Kinase
2020 · Yuqin Song, Keshu Zhou, et al. · Clinical Cancer Research · 184
Zanubrutinib in relapsed/refractory mantle cell lymphoma: long-term efficacy and safety results from a phase 2 study
2022 · Yuqin Song, Keshu Zhou, et al. · Blood · 175
Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with the BTK inhibitor zanubrutinib: phase 2, single-arm, multicenter study
2020 · Wei Xu, Shenmiao Yang, et al. · Journal of Hematology & Oncology · 126
PDF
HOXBLINC long non-coding RNA activation promotes leukemogenesis in NPM1-mutant acute myeloid leukemia
2021 · Ganqian Zhu, Huacheng Luo, et al. · Nature Communications · 77
PDF
Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002)
2021 · Yuankai Shi, Jianqiu Wu, et al. · Journal of Hematology & Oncology · 65
PDF
Oral all-trans retinoic acid plus danazol versus danazol as second-line treatment in adults with primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial
2017 · Fei-Er Feng, Ru Feng, et al. · The Lancet Haematology · 52
Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor–Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321)
2025 · Jeff P. Sharman, Talha Munir, et al. · Journal of Clinical Oncology · 48
Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma
2017 · Xiaoxiao Hao, Yongqiang Wei, et al. · Oncotarget · 43
PDF
Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study
2024 · Yan Gao, Haixia He, et al. · Signal Transduction and Targeted Therapy · 41
Low lymphocyte-to-monocyte ratio predicts unfavorable prognosis in non-germinal center type diffuse large B-cell lymphoma
2014 · Xiaolei Wei, Fen Huang, et al. · Leukemia Research · 41
Safety and Activity of the Investigational Bruton Tyrosine Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Mantle Cell Lymphoma from a Phase 2 Trial
2018 · Yuqin Song, Keshu Zhou, et al. · Blood · 38
Low prognostic nutritional index predicts poor outcome in diffuse large B-cell lymphoma treated with R-CHOP
2016 · Qinjun Zhou, Yongqiang Wei, et al. · International Journal of Hematology · 37
Herpesvirus-Associated Central Nervous System Diseases after Allogeneic Hematopoietic Stem Cell Transplantation
2013 · Meiqing Wu, Fen Huang, et al. · PLoS ONE · 36
PDF
Zanubrutinib monotherapy in relapsed/refractory mantle cell lymphoma: a pooled analysis of two clinical trials
2021 · Keshu Zhou, Dehui Zou, et al. · Journal of Hematology & Oncology · 35
PDF
The Expression of CD30 Based on Immunohistochemistry Predicts Inferior Outcome in Patients with Diffuse Large B-Cell Lymphoma
2015 · Xiaoxiao Hao, Xiaolei Wei, et al. · PLoS ONE · 29
PDF
Lung MRI of invasive fungal infection at 3 Tesla: evaluation of five different pulse sequences and comparison with multidetector computed tomography (MDCT)
2014 · Chenggong Yan, Xiangliang Tan, et al. · European Radiology · 28
Anti-PD-1 Antibody (Sintilimab) Plus Histone Deacetylase Inhibitor (Chidamide) for the Treatment of Refractory or Relapsed Extranodal Natural Killer/T Cell Lymphoma, Nasal Type (r/r-ENKTL): Preliminary Results from a Prospective, Multicenter, Single-Arm, Phase Ib/II Trial (SCENT)
2020 · Yan Gao, Huiqiang Huang, et al. · Blood · 26
E pstein– B arr virus ( EBV ) load in cerebrospinal fluid and peripheral blood of patients with EBV ‐associated central nervous system diseases after allogeneic hematopoietic stem cell transplantation
2013 · Q.‐F. Liu, Y.‐W. Ling, et al. · Transplant Infectious Disease · 25
Rituximab plus chemotherapy as first-line treatment in Chinese patients with diffuse large B-cell lymphoma in routine practice: a prospective, multicentre, non-interventional study
2016 · Jianqiu Wu, Yongping Song, et al. · BMC Cancer · 23
PDF
Antifungal Agents for Secondary Prophylaxis Based on Response to Initial Antifungal Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients with Prior Pulmonary Aspergillosis
2014 · Qifa Liu, Ren Lin, et al. · Transplantation and Cellular Therapy · 23
A Multi-Center, Real-World Study of Chidamide for Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas in China
2021 · Weiping Liu, Donglu Zhao, et al. · Frontiers in Oncology · 21
PDF
Long-term outcomes of HLA-matched sibling compared with mismatched related and unrelated donor hematopoietic stem cell transplantation for chronic phase chronic myelogenous leukemia: a single institution experience in China
2010 · Qi-fa Liu, Xiao-jun Xu, et al. · Annals of Hematology · 21
Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients With Diffuse Large B-Cell Lymphoma
2021 · Xiaolei Wei, Jingxia Zheng, et al. · Frontiers in Oncology · 19
PDF
Intrathecal rituximab for EBV-associated post-transplant lymphoproliferative disorder with central nervous system involvement unresponsive to intravenous rituximab-based treatments: a prospective study
2015 · M Wu, J Sun, et al. · Bone Marrow Transplantation · 19
Zanubrutinib in Patients With Relapsed/refractory Mantle Cell Lymphoma
2019 · Y. Song, K. Zhou, et al. · Hematological Oncology · 18
Works count: 173
Citation count: 1,552
H-index: 21
I10-index: 34
Year
Topic
Type